Search

Author/Creator Hojo, Seiichiro

11. Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle‐controlled, multicenter clinical trial. Issue 7 (18th June 2014)

Authors:
Furue, Masutaka; Kitahara, Yasumi; Akama, Hideto; Hojo, Seiichiro; Hayashi, Nobukazu; Nakagawa, Hidemi; The JAPANESE E6005 Study Investigators
Journal:
Journal of dermatology
Issue:
Volume 41:Issue 7(2014)
Page Start:
577
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis. Issue 1 (2nd January 2018)

Authors:
Tanaka, Yoshiya; Takeuchi, Tsutomu; Umehara, Hisanori; Nanki, Toshihiro; Yasuda, Nobuyuki; Tago, Fumitoshi; Kawakubo, Makoto; Kitahara, Yasumi; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio
Journal:
Modern rheumatology
Issue:
Volume 28:Issue 1(2018)
Page Start:
58
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. SAT0126 A PHASE 2 STUDY OF E6011, AN ANTI-FRACTALKINE MONOCLONAL ANTIBODY, IN PATIENTS WITH RHEUMATOID ARTHRITIS INADEQUATELY RESPONDING TO BIOLOGICS. (June 2019)

Authors:
Tanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Hisaki, Hayato; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
1131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗